Trial intelligence / Profile preview

Long-term topiramate administration in pediatric patients (extension of phase III KW-6485P study)

jRCT2080221336Phase 3

Sponsor
Kyowa Kirin
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of topiramate in epilepsy, sponsored by Kyowa Kirin.

02

Drugs

topiramate
03

Conditions

epilepsy

Beyond the preview

Go deeper on jRCT2080221336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call